Robert Bullington
Ophthalmology · Phoenix, AZNPI 1134114275
Payments from drug & device makers
Across 97 payments — averaging $37.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$432
- Glaukos Corporation$396
- Bausch & Lomb Americas Inc.$375
- Dompe US, Inc.$352
- Bausch & Lomb, A Division Of Bausch Health US, LLC$344
- Sun Pharmaceutical Industries Inc.$336
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,684100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $432 |
| Glaukos Corporation | 4 | $396 |
| Bausch & Lomb Americas Inc. | 14 | $375 |
| Dompe US, Inc. | 11 | $352 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $344 |
| Sun Pharmaceutical Industries Inc. | 9 | $336 |
| Rxsight Inc | 5 | $317 |
| Oyster Point Pharma, Inc. | 7 | $172 |
| Eyevance Pharmaceuticals LLC | 1 | $171 |
| Novartis | 3 | $126 |
| Ivantis, Inc | 1 | $109 |
| AbbVie(2 entities) | 6 | $106 |
| Harrow Eye, LLC | 3 | $82 |
| Genentech USA, Inc. | 1 | $81 |
| Rayner Intraocular Lenses Limited | 3 | $74 |
| Thea Pharma Inc. | 3 | $62 |
| Tarsus Pharmaceuticals, Inc. | 2 | $51 |
| Aerie Pharmaceuticals, Inc. | 2 | $40 |
| Johnson & Johnson Vision Care, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $22 |
| Carl Zeiss Meditec USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iDoseTR$287
- RXSIGHT CONTACT LENS$258
- RXSIGHT INJECTOR CARTRIDGE$258
- RXSIGHT INJECTOR HANDPIECE$258
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$258
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$258
- Flarex$171
- MIEBO$145
- XIIDRA$145
- enVista MX60 IOL$145
- VYZULTA$125
- CEQUA$122
- Clareon$120
- Hydrus$109
- BEOVU$106
How this compares
$3,684 in reported general payments places this provider in the 65th percentile of 310 ophthalmology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 39 | $33,165 |
| RestasisCyclosporine | 21 | $31,311 |
| LumiganBimatoprost | 31 | $19,470 |
| Alphagan PBrimonidine Tartrate | 19 | $6,565 |
| ProlensaBromfenac Sodium | 15 | $5,044 |
| VyzultaLatanoprostene Bunod | 11 | $4,560 |
| Lotemax SmLoteprednol Etabonate | 15 | $3,696 |
| Fluorometholone | 23 | $2,384 |
| Prednisolone Acetate | 51 | $1,570 |
| MoxifloxacinMoxifloxacin Hcl | 83 | $1,404 |
| Latanoprost | 81 | $1,107 |
| Timolol Maleate | 27 | $381 |
| Dorzolamide Hcl | 15 | $205 |
| Acyclovir | 11 | $148 |
| Brimonidine Tartrate | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P | $106 | $57,34671 claims |
| Bausch & Lomb Americas Inc.Miebo, Vyzulta | $375 | $37,72550 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Lotemax Sm | $344 | $8,74030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 310 ophthalmology providers in Arizona.
Other ophthalmology in Phoenix
- Ramin SchadluPhoenix$1.8M
- John CasonPhoenix$1.7M
- Benjamin HellerPhoenix$1.1M
- Neal PalejwalaPhoenix$627K
- Pravin DugelPhoenix$479K
- Robert GrossPhoenix$268K
- Sujit IttyPhoenix$216K
- Jung DaoPhoenix$213K
- Karim JamalPhoenix$101K
- Nishi ShahPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.